Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Shahbazi-Gahrouei D et al. | 2014 | intact cell/cell culture, human adipose-derived mesenchymal stem cells | 50/60 Hz, magnetic field | 0.5–1 mT |
Wocik-Piotrowicz K et al. | 2014 | intact cell/cell culture, U937 (human leukemic monocyte cell line) | magnetic field, static magnetic field, low frequency, 50/60 Hz, DC, co-exposure | 2–6.5 mT |
Giorgi G et al. | 2014 | intact cell/cell culture, human neuroblastoma cell line (BE(2)C) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Huang CY et al. | 2014 | intact cell/cell culture, human epidermal keratinocytes (derived from neonatal foreskin) and HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz | 1.5 mT |
Kakikawa M et al. | 2014 | intact cell/cell culture, bacterium, <i>E. coli</i>/JE5595 | magnetic field, 50/60 Hz, co-exposure | 50 mT |
Reale M et al. | 2014 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Huang CY et al. | 2014 | intact cell/cell culture, HaCaT cells (human keratinocytes) partially transfected with CHK2 siRNA | magnetic field, 50/60 Hz, shielding/field deprivation | 1.5 mT |
de Groot MW et al. | 2014 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz, co-exposure | 1–1,000 µT |
Brisdelli F et al. | 2014 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz, co-exposure | 0.01–2 mT |
Jia HL et al. | 2014 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz, co-exposure | 400 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.